Template:Cellulitis antibiotics/es: Difference between revisions

(Created page with "Template:Cellulitis antibiotics")
 
(Created page with "*Personalizar los antibióticos según el antibiograma regional*<ref>Stevens D, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-e52</ref>")
 
Line 1: Line 1:
<noinclude><languages/></noinclude>
<noinclude><languages/></noinclude>
<div lang="en" dir="ltr" class="mw-content-ltr">
*Personalizar los antibióticos según el antibiograma regional*<ref>Stevens D, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-e52</ref>
''Tailor antibiotics by regional antibiogram''<ref>Stevens D, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-e52</ref>
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
=====Ambulatorio=====
====Outpatient====
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
*Cobertura principalmente para [[Special:MyLanguage/Strep|Estreptococo]]*<br />
''Coverage primarily for [[Special:MyLanguage/Strep|Strep]]''<br />
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
*[Cobertura principalmente para [[Special:MyLanguage/Strep|Estreptococo]]](https://wiki.aach.org/Special:MyLanguage/Strep)
''[[Special:MyLanguage/MRSA|MRSA]] coverage only necessary if cellulitis associated with: purulence, penetrating trauma, known MRSA colonization, IV drug use, or SIRS''<ref name="IDSA guidelines">Stevens D, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-e52</ref>
*La cobertura para [[Special:MyLanguage/MRSA|MRSA]] solo es necesaria si la celulitis está asociada con: purulencia, trauma penetrante, colonización conocida por MRSA, uso de drogas IV o SIRS<ref name="IDSA guidelines">Stevens D, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-e52</ref>
*5 day treatment duration, unless symptoms do not improve within that timeframe<ref name="IDSA guidelines" />
*Duración del tratamiento de 5 días, a menos que los síntomas no mejoren en ese período de tiempo<ref name="IDSA guidelines" />
**[[Special:MyLanguage/Cephalexin|Cephalexin]] 500mg PO q6hrs '''OR'''
**[[Special:MyLanguage/Cephalexin|Cefalexina]] 500mg VO cada 6 horas '''O'''
***Add [[Special:MyLanguage/TMP/SMX|TMP/SMX]] DS 1 tab PO BID<ref>Cadena J, et al. Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy 55.12 (2011): 5430-5432.</ref> if [[Special:MyLanguage/MRSA|MRSA]] is suspected
***Agregar [[Special:MyLanguage/TMP/SMX|TMP/SMX]] DS 1 comprimido VO cada 12 horas<ref>Cadena J, et al. Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy 55.12 (2011): 5430-5432.</ref> si se sospecha [[Special:MyLanguage/MRSA|MRSA]]
***Most cases of non-purulent cellulitis are caused by Strep. In these cases, the addition of TMP/SMX has been demonstrated to offer no clinical benefit over cephalexin alone.<ref>Pallin D, et al. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clinical infectious diseases 56.12 (2013): 1754-1762</ref>
***La mayoría de los casos de celulitis no purulenta son causados por Estreptococo. En estos casos, se ha demostrado que la adición de TMP/SMX no ofrece beneficio clínico sobre la cefalexina sola.<ref>Pallin D, et al. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clinical infectious diseases 56.12 (2013): 1754-1762</ref>
**[[Special:MyLanguage/Clindamycin|Clindamycin]] 450mg PO TID covers both Strep and Staph
**[[Special:MyLanguage/Clindamycin|Clindamicina]] 450mg VO cada 8 horas cubre tanto Estreptococo como Estafilococo
**Tetracyclines (like [[Special:MyLanguage/Doxycycline|Doxycycline]]) should be avoided in non-purulent cellulitis due to high rates of Strep resistance<ref>Traub, W and Leonhard, B. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 43.1 (1997):10-20.</ref>
**Las tetraciclinas (como la [[Special:MyLanguage/Doxycycline|Doxiciclina]]) deben evitarse en la celulitis no purulenta debido a las altas tasas de resistencia del Estreptococo<ref>Traub, W and Leonhard, B. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 43.1 (1997):10-20.</ref>
</div>




<div lang="en" dir="ltr" class="mw-content-ltr">
=====Hospitalizado=====
====Inpatient====
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
*[[Special:MyLanguage/Vancomycin|Vancomicina]] 20mg/kg IV cada 12 horas '''O'''
*[[Special:MyLanguage/Vancomycin|Vancomycin]] 20mg/kg IV q12hrs '''OR'''
*[[Special:MyLanguage/Clindamycin|Clindamicina]] 600mg IV cada 8 horas '''O'''
*[[Special:MyLanguage/Clindamycin|Clindamycin]] 600mg IV q8hrs '''OR'''
*[[Special:MyLanguage/Linezolid|Linezolid]] 600mg IV cada 12 horas '''O'''
*[[Special:MyLanguage/Linezolid|Linezolid]] 600mg IV q12hrs '''OR'''
*[[Special:MyLanguage/Daptomycin|Daptomicina]] 4mg/kg IV una vez al día
*[[Special:MyLanguage/Daptomycin|Daptomycin]] 4mg/kg IV once daily
</div>




<div lang="en" dir="ltr" class="mw-content-ltr">
=====Celulitis relacionada con agua salada=====
====Saltwater related cellulitis====
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
*cobertura extendida para [[Special:MyLanguage/Vibrio vulnificus|Vibrio vulnificus]]
''coverage extended for [[Special:MyLanguage/Vibrio vulnificus|Vibrio vulnificus]]''
*[[Special:MyLanguage/Doxycycline|Doxiciclina]] 100mg VO/IV cada 12 horas + [[Special:MyLanguage/Cefepime|Cefepima]] 1g IV cada 12 horas por 10 días
*[[Special:MyLanguage/Doxycycline|Doxycycline]] 100mg PO/IV q12hrs daily + [[Special:MyLanguage/Cefepime|Cefepime]] 1g IV q12hrs x 10 days
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacina]] 400mg IV cada 12 horas por 10 días
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 400mg IV q12hrs x 10 days
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacina]] 750mg VO cada 12 horas por 10 días
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 750mg PO q12hrs x 10 days
</div>




<div lang="en" dir="ltr" class="mw-content-ltr">
=====Celulitis relacionada con agua dulce=====
====Freshwater related cellulitis====
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
*cobertura extendida para [[Special:MyLanguage/Aeromonas sp|Aeromonas sp]]
''coverage extended for [[Special:MyLanguage/Aeromonas sp|Aeromonas sp]]''
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacina]] 400mg IV cada 12 horas por 10 días
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 400mg IV q12hrs  x 10 days
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacina]] 500mg VO cada 12 horas por 10 días
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 500mg PO q12hrs x 10 days
*[[Special:MyLanguage/TMP/SMX|TMP/SMX]] 2 comprimidos DS (5mg/kg) VO cada 12 horas por 10 días
*[[Special:MyLanguage/TMP/SMX|TMP/SMX]] 2 DS tablets (5mg/kg) PO q12hrs x 10 days
*[[Special:MyLanguage/Ceftriaxone|Ceftriaxona]] 1g (50mg/kg) IV cada 24 horas
*[[Special:MyLanguage/Ceftriaxone|Ceftriaxone]] 1g (50mg/kg) IV q24hrs
</div>

Latest revision as of 16:03, 27 January 2026

Other languages:
  • Personalizar los antibióticos según el antibiograma regional*[1]
Ambulatorio
  • [Cobertura principalmente para Estreptococo](https://wiki.aach.org/Special:MyLanguage/Strep)
  • La cobertura para MRSA solo es necesaria si la celulitis está asociada con: purulencia, trauma penetrante, colonización conocida por MRSA, uso de drogas IV o SIRS[2]
  • Duración del tratamiento de 5 días, a menos que los síntomas no mejoren en ese período de tiempo[2]
    • Cefalexina 500mg VO cada 6 horas O
      • Agregar TMP/SMX DS 1 comprimido VO cada 12 horas[3] si se sospecha MRSA
      • La mayoría de los casos de celulitis no purulenta son causados por Estreptococo. En estos casos, se ha demostrado que la adición de TMP/SMX no ofrece beneficio clínico sobre la cefalexina sola.[4]
    • Clindamicina 450mg VO cada 8 horas cubre tanto Estreptococo como Estafilococo
    • Las tetraciclinas (como la Doxiciclina) deben evitarse en la celulitis no purulenta debido a las altas tasas de resistencia del Estreptococo[5]


Hospitalizado


Celulitis relacionada con agua salada


Celulitis relacionada con agua dulce
  1. ↑ Stevens D, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-e52
  2. ↑ 2.0 2.1 Stevens D, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-e52
  3. ↑ Cadena J, et al. Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy 55.12 (2011): 5430-5432.
  4. ↑ Pallin D, et al. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clinical infectious diseases 56.12 (2013): 1754-1762
  5. ↑ Traub, W and Leonhard, B. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 43.1 (1997):10-20.
Retrieved from "https://www.wikem.org/w/index.php?title=Template:Cellulitis_antibiotics/es&oldid=385304"